Changeflow GovPing Healthcare Novosorb BTM Burn Trademark Application
Routine Notice Added Final

Novosorb BTM Burn Trademark Application

Email

Summary

The USPTO has received an intent-to-use trademark application for "NOVOSORB BTM BURN" filed by an unnamed applicant. The application covers a range of surgical grafts, artificial skin, and wound care products made from artificial and biological materials.

What changed

The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application (TM99492232) for the mark "NOVOSORB BTM BURN." The application, filed on November 12, 2025, with an intent-to-use date of March 22, 2026, covers a broad spectrum of medical products. These include surgical tissue reconstruction grafts made from artificial materials (bioresorbable, porous, foam, sheet, mesh), artificial skin for medical and surgical purposes, bioresorbable polymer scaffolds for burn and wound care, surgical meshes, foams, and slings, as well as biological tissue grafts and implants.

This filing represents a new trademark application for a specific product line in the medical device and wound care sector. While this is not a regulatory rule or enforcement action, it signifies a potential new market entrant or product launch that may impact existing market players. Compliance officers in the pharmaceutical and medical device sectors should note this application as an indicator of potential new product development and competitive landscape shifts. No immediate compliance actions are required based on this trademark filing.

Source document (simplified)

← USPTO Trademark Applications

NOVOSORB BTM BURN

Intent to Use TM99492232 Kind: intenttouse Mar 22, 2026

Abstract

Surgical tissue reconstruction grafts being made from artificial materials; bioresorbable surgical tissue reconstruction grafts being made from artificial materials; surgical tissue reconstruction grafts being made from artificial materials which are porous; surgical tissue reconstruction grafts being made from artificial materials in the form of foam, sheet or mesh; surgical grafts made of artificial materials for use in soft tissue reinforcement and augmentation; artificial skin for medical purposes; artificial skin for surgical purposes; artificial skin replacing membranes for medical purposes; bioresorbable polymer scaffold products for use in burn and wound care; bioresorbable polymer scaffold for use in chronic or acute wound care; surgical grafts and implants made from artificial materials for use in soft tissue repair; implantable scaffolds, surgical tissue grafts and reconstruction implants made from artificial materials in the form of foam, sheet or mesh for use in repair and treatment of chronic or acute wounds; surgical mesh comprised primarily of artificial materials; surgical foams being implants made of artificial materials for use in tissue reconstruction in tissue reconstruction; surgical slings being tissue implants made of artificial materials; implantable scaffolds, surgical tissue grafts and reconstruction implants made from artificial materials for use in the repair and treatment of internal and external wounds; surgical apparatus in the nature of implantable biodegradable porous devices made of artificial material for use in the repair and treatment of internal and external wounds; implantable scaffolds, surgical grafts and implants made from artificial materials for use in soft tissue repair, reinforcement and augmentation; biodegradable prosthetic, tissues for visceral use; surgical implants and grafts made of artificial materials for dermal repair and regeneration; surgical reconstruction implants and skin grafts made of artificial materials for treatment and repair of burns; surgical implants and skin grafts made of artificial materials for wound repair and closure; Biological tissue grafts, namely bioresorbable grafts for use in tissue regeneration; biological skin bioresorbable grafts for use in surgery; medical plasters; medical and wound dressings; skin grafts, plasters and dressings all being for use in burn and wound care; plasters and dressings all being for use in chronic or acute wound care; biological bioresorbable tissue grafts and bioresorbable implants comprised of living tissue for use in soft tissue repair; surgical slings being tissue implants made of biological materials

Filing Date

2025-11-12

View original document →

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99492232

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Medical Device Manufacturing Wound Care
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Medical Devices Intellectual Property

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Trademarks - Medical Devices (Class 010) publishes new changes.

Free. Unsubscribe anytime.